Sunday , December 22 2024
Home / SNB & CHF / Covid: second vaccine approved for use on 12 to 17 year olds in Switzerland

Covid: second vaccine approved for use on 12 to 17 year olds in Switzerland

Summary:
© Marcos del Mazo | Dreamstime.com Swissmedic, Switzerland’s drug approval agency, extended approval of the Moderna Covid-19 vaccine for use on 12 to 17 year olds this week. On 9 August 2021, Swissmedic said that it had carefully examined an application from Moderna Switzerland and had decided to extend the temporary authorisation for the use ...

Topics:
Investec considers the following as important: , , , , , , ,

This could be interesting, too:

Investec writes Federal parliament approves abolition of imputed rent

Nachrichten Ticker - www.finanzen.ch writes Krypto-Ausblick 2025: Stehen Bitcoin, Ethereum & Co. vor einem Boom oder Einbruch?

Connor O'Keeffe writes The Establishment’s “Principles” Are Fake

Per Bylund writes Bitcoiners’ Guide to Austrian Economics

Covid: second vaccine approved for use on 12 to 17 year olds in Switzerland

© Marcos del Mazo | Dreamstime.com

Swissmedic, Switzerland’s drug approval agency, extended approval of the Moderna Covid-19 vaccine for use on 12 to 17 year olds this week.

On 9 August 2021, Swissmedic said that it had carefully examined an application from Moderna Switzerland and had decided to extend the temporary authorisation for the use of its Spikevax vaccine on 12 to 17 year olds.

The application, which included data on 3,732 vaccinated children aged between 12 and 17, was submitted on 11 June 2021. Those included in the study received the same dose as adults and had a similar immune response to adults aged 18 to 25.

The side effects most frequently experienced by the children aged 12 to 17 in the study were similar to those aged 18 and over. In the clinical trial, the vaccine showed an efficacy against symptomatic disease (at least one symptom and positive PCR test) of about 93% 14 days after the second dose. Side effects usually lasted between one and three days, and were typically more pronounced after the second dose.

Previously, the only vaccine authorised for use on adolescents in Switzerland was the Pfizer/BioNTech vaccine, which had its temporary approval extended to 12 to 15 year olds on 4 June 2021.

More on this:
Swissmedic press release (in French) – Take a 5 minute French test now

For more stories like this on Switzerland follow us on Facebook and Twitter.


Tags: ,,,,,

Covid: second vaccine approved for use on 12 to 17 year olds in SwitzerlandDon’t miss posts anymore!
Subscribe to our newsletter!

About Investec
Investec
Investec is a distinctive Specialist Bank and Asset Manager. We provide a diverse range of financial products and services to our niche client base.

Leave a Reply

Your email address will not be published. Required fields are marked *